MEDICAL DEVICE CONFIGURATION PROCEDURE GUIDANCE RESPONSIVE TO DETECTED GESTURES

    公开(公告)号:US20230005589A1

    公开(公告)日:2023-01-05

    申请号:US17943491

    申请日:2022-09-13

    Abstract: Techniques disclosed herein relate to providing guidance for configuring a medical device to a user in response to detected gestures of the user. In some embodiments, the techniques involve obtaining sensor data indicative of one or more gestures of a user of a medical device, and detecting a configuration procedure being performed on the medical device by the user based on the sensor data, where the configuration procedure includes a sequence of tasks to be performed by the user to configure the medical device. The techniques also involve determining one or more tasks of the configuration procedure that have been performed by the user based on the sensor data, identifying a subsequent task of the configuration procedure to be performed by the user based on the one or more tasks, and generating guidance information for performing the subsequent task of the configuration procedure.

    MANAGEMENT OF INSUFFICIENT HYPOGLYCEMIA RESPONSE

    公开(公告)号:US20210361866A1

    公开(公告)日:2021-11-25

    申请号:US17394121

    申请日:2021-08-04

    Abstract: A system includes one or more processors and one or more processor-readable storage media storing instructions which, when executed by the one or more processors, cause performance of obtaining an insulin-on-board (IOB) value, wherein the IOB value is a quantity of insulin remaining in a patient following delivery of a bolus of insulin, scaling a total daily dose (TDD) value by a factor, to generate a result having a value that is less than the TDD value, based on determining that the IOB value is greater than the result, identifying a condition in which the patient's glucose level will continue to decrease after suspension of basal insulin dosage delivery, and responsive to identifying the condition, causing performance of an action for preventing the patient's glucose level from falling into a hypoglycemic range in combination with the suspension of basal insulin dosage delivery.

Patent Agency Ranking